Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy
Active, not recruiting · NCT05169060 · Registry updated 2026-04-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy | Diabetes Complications, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, diabetes mellitus, diabetic neuropathy, endocrine system disorder, glucose metabolism disease, metabolic disease, nervous system disorder, neuromuscular disease, peripheral nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-06 | NCT05169060 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 617 |
| Oregon Health and Science University | 244 |
| University of Iowa | 102 |
| University of Michigan | 394 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oregon Health Science University | Portland | United States | 8 |
| University of Iowa | Iowa City | United States | 4 |